(NASDAQ: COO) Cooper Companies's forecast annual revenue growth rate of 6.06% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.02%.
Cooper Companies's revenue in 2025 is $3,895,400,000.On average, 8 Wall Street analysts forecast COO's revenue for 2025 to be $821,942,924,899, with the lowest COO revenue forecast at $820,154,464,988, and the highest COO revenue forecast at $825,014,701,096. On average, 7 Wall Street analysts forecast COO's revenue for 2026 to be $876,631,957,328, with the lowest COO revenue forecast at $872,271,476,115, and the highest COO revenue forecast at $883,971,408,817.
In 2027, COO is forecast to generate $923,676,576,016 in revenue, with the lowest revenue forecast at $921,900,689,810 and the highest revenue forecast at $926,897,640,017.